SCHEMBL9021896

SCHEMBL9021896

C=CCn1cc(C)c(=O)[nH]c1=O

nearest known ligand 0.64

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TK1 P04183 12/20 0.56
MAPK1 P28482 1/20 0.54
HPGD P15428 1/20 0.53
TK2 O00142 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6714052 0.84 TK1 (0.57) TK1MAPK1HPGDTK2
SCHEMBL9891076 0.81 TK1 (0.62) TK1MAPK1HPGDTK2
SCHEMBL12410891 0.81 TK1 (0.41) TK1MAPK1
SCHEMBL19196342 0.81 TK1 (0.62) TK1MAPK1HPGDTK2
SCHEMBL27708058 0.79 MAPK1 (0.59) TK1MAPK1HPGDTK2
SCHEMBL17791229 0.79 CYP1A2 (0.49) TK1
SCHEMBL4564516 0.79 GRIA1 (0.49)
SCHEMBL148953 0.79 CYP3A4 (0.37) TK1TK2
SCHEMBL19181903 0.78 TK1 (0.63) TK1MAPK1TK2
SCHEMBL2183944 0.77 MAPK1 (0.61) TK1MAPK1HPGDTK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4426859-B1 PRIMER SETS AND METHODS AND KITS INCORPORATING THE PRIMER SETS ILLUMINA INC (US) 2026-04-15 EP disclosed
US-20250084477-A1 PRIMER SETS AND METHODS AND KITS INCORPORATING THE PRIMER SETS ILLUMINA, INC. 2025-03-13 US disclosed
EP-4426859-A1 PRIMER SETS AND METHODS AND KITS INCORPORATING THE PRIMER SETS Illumina, Inc. (US) 2024-09-11 EP disclosed
CN-117813400-A Primer sets and methods and kits for incorporating the same 因美纳有限公司 2024-04-02 CN disclosed
WO-2023081654-A1 PRIMER SETS AND METHODS AND KITS INCORPORATING THE PRIMER SETS ILLUMINA, INC. (US) 2023-05-11 WO disclosed
US-8853416-B2 Chemical compounds Janssen Pharmaceuticals, Inc. (US) 2014-10-07 US disclosed
US-8575291-B2 Thermoplastic silicone resin NITTO DENKO CORPORATION (JP) 2013-11-05 US disclosed
US-8575291-B2 Thermoplastic silicone resin NITTO DENKO CORPORATION (JP) 2013-11-05 US disclosed
US-8575291-B2 Thermoplastic silicone resin NITTO DENKO CORPORATION (JP) 2013-11-05 US disclosed
US-20130066033-A1 THERMOPLASTIC SILICONE RESIN NITTO DENKO CORPORATION (JP) 2013-03-14 US disclosed
US-20130066033-A1 THERMOPLASTIC SILICONE RESIN NITTO DENKO CORPORATION (JP) 2013-03-14 US disclosed
US-20130066033-A1 THERMOPLASTIC SILICONE RESIN NITTO DENKO CORPORATION (JP) 2013-03-14 US disclosed
EP-2567998-A1 Thermoplastic silicone resin NITTO DENKO CORPORATION (JP) 2013-03-13 EP disclosed
EP-0530407-B1 Substituted, nucleoside derivatives, methods for their preparation and pharmaceutical compositions containing them STICHTING REGA V Z W (BE) 1996-06-05 EP disclosed
EP-0530407-A1 Substituted, nucleoside derivatives, methods for their preparation and pharmaceutical compositions containing them Stichting REGA V.Z.W. (BE) 1993-03-10 EP disclosed